Year |
Citation |
Score |
2016 |
Johns SC, Yin X, Jeltsch M, Bishop JR, Schuksz M, El Ghazal R, Wilcox-Adelman SA, Alitalo K, Fuster MM. Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis. Circulation Research. PMID 27225479 DOI: 10.1161/Circresaha.116.308504 |
0.379 |
|
2011 |
Zak BM, Schuksz M, Koyama E, Mundy C, Wells DE, Yamaguchi Y, Pacifici M, Esko JD. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones. Bone. 48: 979-87. PMID 21310272 DOI: 10.1016/J.Bone.2011.02.001 |
0.424 |
|
2008 |
Schuksz M, Fuster MM, Brown JR, Crawford BE, Ditto DP, Lawrence R, Glass CA, Wang L, Tor Y, Esko JD. Surfen, a small molecule antagonist of heparan sulfate. Proceedings of the National Academy of Sciences of the United States of America. 105: 13075-80. PMID 18725627 DOI: 10.1073/Pnas.0805862105 |
0.631 |
|
2007 |
Fuster MM, Wang L, Castagnola J, Sikora L, Reddi K, Lee PH, Radek KA, Schuksz M, Bishop JR, Gallo RL, Sriramarao P, Esko JD. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. The Journal of Cell Biology. 177: 539-49. PMID 17470635 DOI: 10.1083/Jcb.200610086 |
0.566 |
|
2007 |
Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 446: 1030-7. PMID 17460664 DOI: 10.1038/Nature05817 |
0.524 |
|
2007 |
Elson-Schwab L, Garner OB, Schuksz M, Crawford BE, Esko JD, Tor Y. Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. The Journal of Biological Chemistry. 282: 13585-91. PMID 17311923 DOI: 10.1074/Jbc.M700463200 |
0.617 |
|
2007 |
Fuster MM, Wang L, Castagnola J, Sikora L, Reddi K, Lee PH, Radek KA, Schuksz M, Bishop JR, Gallo RL, Sriramarao P, Esko JD. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis The Journal of Experimental Medicine. 204: i16-i16. DOI: 10.1084/JEM2045OIA16 |
0.442 |
|
Show low-probability matches. |